Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2020;31(3):358-61
Article Links
A Rare Case with Systemic Lupus Erythematosus Manifested by two Different Neurologic Entities; Guillain Barre Syndrome and Posterior Reversible Encephalopathy Syndrome
Firdevs Ulutaş1, Veli Çobankara1, Uğur Karasu1, Nuri Baser2, Ismail Hakkı Akbudak3
Authors Information

1. Department of Rheumatology, 2. Department of Internal Medicine, and 3. Department of Intensive Care Unit, Faculty of Medicine, Pamukkale University, Denizli, Turkey

Firdevs Ulutaş, Veli Çobankara, Uğur Karasu, Ismail Hakkı Akbudak

Keywords: Systemic lupus erythematosus, Guillain-Barre Syndrome, posterior reversible encephalopathy syndrome
References
  1. Kampylafka E, Alexopoulos H, Kosmidis M, Panagiotakos DB, Vlachoyiannopoulos PG, Dalakas MC, et al. Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3‐year prospective study of 370 patients. PLoS ONE 2013;8:e55843.
  2. Hanly JG, Urowitz MB, Sanchez-Guerrero J, Bae SC, Gordon C, Wallace DJ, et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 2007;56:265-73.
  3. Nadri Q, Althaf MM. Guillian-Barre syndrome as the initial presentation of systemic lupus erythematosus-case report and review of literature. Ann Saudi Med 2015;35:263-5. 
  4. Tatjana Zekic, Mirjana Stanic Benic, Ronald Antulov, Antončić I, Novak S. The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients. Rheumatol Int 2017;37:2105-14.
  5. Chen A, Kim J, Henderson G, Berkowitz A. Posterior Reversible Encephalopathy Syndrome in Guillain-Barre Syndrome. J Clin Neurosci 2015;22:914-6.
  6. Lovie J, Igbokwe E, Hinchey J. Posterior Reversible Encephalopathy Syndrome associated with the Dysautonomia of Guillain-Barre Syndrome. Neurol Bull 2009;1:7-10.
  7. Sanpei Y, Hanazono A, Kamada S, Sugawara M. Guillain Barre Syndrome and Posterior Reversible Encephalopathy Syndrome following Spinal Surgery. Case Rep Neurol 2019;11(3):284-9.
  8. Drye C, Bose S, Pathireddy S, Aeddula NR. Guillain-Barre syndrome with concurrent posterior reversible encephalopathy syndrome and hyponatremia: mere coincidence. BMJ Case Rep 2019;12(7). pii: e229749.
  9. Yonekura S, Anno T, Kobayashi N. Posterior Reversible Encephalopathy Syndrome and Guillain-Barre syndrome after Head Injury: Case Report. Neurol Med Chir (Tokyo) 2018;58(10):453-8.
  10. Kakati S, Barman B, Ahmed SU, Hussain M. Neurological manifestations in systemic lupus erythematosus: a single centre study from North East India. J Clin Diagn Res 2017;11:OC05–OC09.
  11. Van Doorn P. Diagnosis, treatment and prognosis of Guillain-Barre syndrome (GBS). La Presse Medicale 2013;42:e193-e201.
  12. Toledano P, Orueta R, Rodriguez-Pinto I, Valls-Solé J, Cervera R, Espinosa G. Peripheral nervous system involvement in systemic lupus erythematosus: prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single centre. Autoimmun Rev 2017;16:750-5.
  13. Chevret S, Hughes RA, Annane D, Cochrane Neuromuscular Group. Plasma Exchange, Intravenous immunoglobulin for Guillain Barre syndrome. Cochrane Database Syst Rev 2017;(2):CD001798.
  14. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010;85:427-32.
  15. Houssiau FA, Vasconcelos C, D’Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 2002;46:2121-31.
  16. Jung SM, Moon SJ, Kwok SK, Ju JH, Park KS, Park SH, et al. Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome. Lupus 2013;22:885-91.
  17. Cui Hw, Lei RY, Zhang SG, Han LS, Zhang BA. Clinical features, outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case-control study. Lupus 2019;28(8):961-9.
  18. Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narvaez A, Dávila-Maldonado L, Atisha Y, Llorente L, et al. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 2007;56:1242-50.